Sorafekast 200 mg Sorafekast 200 mg contains Sorafenib 200 mg, an oral targeted therapy used to treat certain advanced cancers. It helps control the growth of cancer cells by blocking the signals they need to multiply and by reducing the formation of new blood vessels that nourish tumors. This dual action helps slow the progression of the disease and supports long-term cancer management. Sorafekast is commonly prescribed for advanced liver cancer, kidney cancer, and certain types of thyroid cancer, and should be taken only under the supervision of an experienced oncologist.